<?xml version="1.0"?>
<oembed><version>1.0</version><provider_name>Frezza Partners</provider_name><provider_url>https://frezzapartners.com/en/</provider_url><author_name>Frezza Partners</author_name><author_url>https://frezzapartners.com/en/author/fr3zz4partn3rs/</author_url><title>BEI finanzia MolMed per la ricerca - Frezza Partners</title><type>rich</type><width>600</width><height>338</height><html>&lt;blockquote class="wp-embedded-content" data-secret="qkLnLF8dNB"&gt;&lt;a href="https://frezzapartners.com/en/bei-finanzia-molmed-per-la-ricerca/"&gt;BEI finanzia MolMed per la ricerca&lt;/a&gt;&lt;/blockquote&gt;&lt;iframe sandbox="allow-scripts" security="restricted" src="https://frezzapartners.com/en/bei-finanzia-molmed-per-la-ricerca/embed/#?secret=qkLnLF8dNB" width="600" height="338" title="&#x201C;BEI finanzia MolMed per la ricerca&#x201D; &#x2014; Frezza Partners" data-secret="qkLnLF8dNB" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"&gt;&lt;/iframe&gt;&lt;script type="text/javascript"&gt;
/* &lt;![CDATA[ */
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&amp;&amp;d.addEventListener&amp;&amp;"undefined"!=typeof URL&amp;&amp;(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&amp;&amp;!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i&lt;o.length;i++)o[i].style.display="none";for(i=0;i&lt;a.length;i++)s=a[i],e.source===s.contentWindow&amp;&amp;(s.removeAttribute("style"),"height"===t.message?(1e3&lt;(r=parseInt(t.value,10))?r=1e3:~~r&lt;200&amp;&amp;(r=200),s.height=r):"link"===t.message&amp;&amp;(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&amp;&amp;n.host===r.host&amp;&amp;l.activeElement===s&amp;&amp;(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r&lt;s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
//# sourceURL=https://frezzapartners.com/wp-includes/js/wp-embed.min.js
/* ]]&gt; */
&lt;/script&gt;
</html><thumbnail_url>https://frezzapartners.com/wp-content/uploads/2019/12/BEI-770x500-1.jpeg</thumbnail_url><thumbnail_width>770</thumbnail_width><thumbnail_height>500</thumbnail_height><description>photo by &nbsp; La Banca Europea per gli Investimenti (BEI) ha concesso un finanziamento di 15 milioni di euro a MolMed, societ&#xE0; biotech italiana quotata a Piazza Affari. Il finanziamento dar&#xE0; la possibilit&#xE0; all&#x2019;azienda biotech di raggiungere una serie di criteri di prestazione condivisi, che costituiranno il sostegno per il piano di sviluppo di crescita sostenibile. Il finanziamento ha la garanzia del Fondo Europeo per gli Investimenti Strategici (EFSI), pilastro centrale del piano Juncker. La Banca dunque garantir&#xE0; un contributo...</description></oembed>
